Liam J. Kelly
Net Worth
Last updated:
What is Liam J. Kelly net worth?
The estimated net worth of Mr. Liam J. Kelly is at least $41,412,082 as of 27 Dec 2023. He owns shares worth $2,295,512 as insider, has earned $17,006,570 from insider trading and has received compensation worth at least $22,110,000 in Teleflex Incorporated.
What is the salary of Liam J. Kelly?
Mr. Liam J. Kelly salary is $2,010,000 per year as Chairman, Pres & Chief Executive Officer in Teleflex Incorporated.
How old is Liam J. Kelly?
Mr. Liam J. Kelly is 58 years old, born in 1967.
What stocks does Liam J. Kelly currently own?
As insider, Mr. Liam J. Kelly owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Teleflex Incorporated (TFX) | Chairman, Pres & Chief Executive Officer | 18,469 | $124.29 | $2,295,512 |
What does Teleflex Incorporated do?
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Liam J. Kelly insider trading
Teleflex Incorporated
Mr. Liam J. Kelly has made 7 insider trades between 2014-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 26,256 units of TFX stock on 27 Dec 2023. As of 27 Dec 2023 he still owns at least 18,469 units of TFX stock.
Teleflex Incorporated key executives
Teleflex Incorporated executives and other stock owners filed with the SEC:
- Mr. Cameron P. Hicks (60) Corporation Vice President & Chief HR Officer
- Mr. Liam J. Kelly (58) Chairman, Pres & Chief Executive Officer
- Mr. Thomas E. Powell (63) Executive Vice President & Chief Financial Officer